Human CNMD (Leukocyte Cell-Derived Chemotaxin 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-01694P

SDS-PAGE analysis of Human CNMD (Leukocyte Cell-Derived Chemotaxin 1) - Recombinant Protein, CAT# BLT-01694P, showing >90% purity under 15% SDS-PAGE (Reduced)
Human CNMD (Leukocyte Cell-Derived Chemotaxin 1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-01694P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human Leukocyte Cell Derived Chemotaxin 1 (LECT1/CNMD) Protein |
Product Overview | This recombinant human Leukocyte Cell Derived Chemotaxin 1 (LECT1/CNMD) protein includes amino acids 134-334aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | O75829 |
Recommended Name | Leukocyte cell-derived chemotaxin 1 |
Gene Name | CNMD |
Synonyms | leukocyte cell-derived chemotaxin 1 isoform 2 precursor , BRICD3, CHM-I, CHM1, MYETS1 |
Species | Human |
Predicted Molecular Mass | 30 kDa |
Expression System | E.coli |
Expression Range | 134-334aa |
Tag | N-6His |
Purity | >90% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Cancer |
Target Function | Bifunctional growth regulator that stimulates the growth of cultured chondrocytes in the presence of basic fibroblast growth factor (FGF) but inhibits the growth of cultured vascular endothelial cells. May contribute to the rapid growth of cartilage and vascular invasion prior to the replacement of cartilage by bone during endochondral bone development. Inhibits in vitro tube formation and mobilization of endothelial cells. Plays a role as antiangiogenic factor in cardiac valves to suppress neovascularization. |
Subcellular Location | [Chondromodulin-1]: Secreted, extracellular space, extracellular matrix. Note=Accumulated in the inter-territorial matrix of cartilage.; [Chondrosurfactant protein]: Endomembrane system; Single-pass membrane protein. |
Protein Family | Chondromodulin-1 family |
Tissue Specificity | Detected in cartilage and cardiac valves (at protein level). Detected in the laminae fibrosa, spongiosa and ventricularis layers of normal cardiac valves (at protein level). Expression is decreased cardiac valves of patients with valvular heart disease (a |